23 - 25 July, 2018 | Sheraton Philadelphia University City Hotel, Philadelphia, PA

Meet the Advisory Board and Speakers

Advisory Board


Ramana Sonty
Ramana Sonty
Director, Global Medical Organization
Johnson & Johnson
Anne B. Cropp
Anne B. Cropp
Chief Scientific Officer
Early Access Care, LLC
Brian J. Malkin
Brian J. Malkin
FDA Counsel
Arent Fox LLP
Beth E. Roxland
Beth E. Roxland
Senior Consultant on Law, Policy, and Ethics; Associate Division of Medical Ethics
NYU Langone School of Medicine
Jennifer  McNary
Jennifer McNary
Patient Advocate
Beauhawks Foundation
Andrew McFadyen
Andrew McFadyen
Executive Director
The Isaac Foundation
Frank Burroughs
Frank Burroughs
CEO
Abigail Alliance for Better Access to Developmental Drugs
Tom Watson
Tom Watson
Pre-approval Access Consultant
TW Consulting Group
Kevin J. Weatherwax
Kevin J. Weatherwax
Administrative Program Director; Co-Chair - Expanded Access Oversight Committee
University of Michigan Health System
Stephen Rosenfeld
Executive Board Chair
Quorum Review IRB

Speakers


Ramana Sonty
Ramana Sonty
Director, Global Medical Organization
Johnson & Johnson
Anne B. Cropp
Anne B. Cropp
Chief Scientific Officer
Early Access Care
Beverly  Harrison
Beverly Harrison
Head, Patient Support
Johnson and Johnson
Karen Bartels
Karen Bartels
Director, Global Medical Affairs, Early Clinical Development and External Research
AstraZeneca
Timothy M Miller
VP & Head, North America Medical Affairs, Rare Diseases
Sanofi Genzyme
Alison Bateman-House
Alison Bateman-House
Assistant Professor – Division of Medical Ethics
NYU
June Wasser
June Wasser
Executive Director and CEO
Reagan-Udall Foundation for the FDA
Marjorie Speers
Executive Director
WCG Foundation
Luiz Andre Magno
Luiz Andre Magno
Global Medical Affairs Leader - Neuroscience
Janssen Pharmaceutical
Jennifer McNary
Jennifer McNary
Patient Advocate
Beauhawks Foundation
Kevin J.  Weatherwax
Kevin J. Weatherwax
Administrative Program Director; Co-Chair - Expanded Access Oversight Committee
University of Michigan Health System